Description

Antibody-drug conjugates are a class of highly innovative targeted antitumor agents formed by the covalent coupling of small molecular cytotoxic drugs (payloads) to monoclonal antibodies via small chemical linkers. Creative biolabs is a well-recognized leader in antibody-drug conjugates (ADCs) developments and we offer a comprehensive set of services to help our clients with ADC preparation, biochemical analysis, and especially, in vitro efficacy evaluation.